Loading…
Sectoral / Thematic · UTI Mutual Fund · AMFI code 100806UTI - Healthcare Fund
Disclosed for 95 months, Jul 2017 to Sep 2026.
Portfolio value
₹776 Cr
down ₹6.3 Cr vs Jul 2023
- Stocks held
- 33
- up 1 vs Jul 2023
- Top 10 weight
- 59.4%
- of the portfolio in its ten largest
- Cash & debt
- 1.8%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 19
UTI - Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In August 2023 it disclosed 33 stocks worth ₹776 Cr, down ₹6.3 Cr from Jul 2023. Its largest positions were Sun Pharmaceutical Industries Limited (12.6%), Cipla Limited (8.9%), Dr. Reddy's Laboratories Limited (7.1%); the ten largest together made up 59.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 77.2% of its equity. Cash and debt stood at 1.8%. Compared with Jul 2023 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
83%
Top-10 weight is higher than 83% of peers
Breadth
18%
Holds more stocks than 18% of peers
Cash
29%
Holds more cash than 29% of peers
Holdings in August 2023
Download CSVEvery line the fund disclosed, with the change against Jul 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 12.60%
- Δ weight
- down 0.56 pts
- Value
- ₹97.8 Cr
- Δ value
- down ₹5.1 Cr
- Status
- Trimmed
- Weight
- 8.91%
- Δ weight
- up 0.43 pts
- Value
- ₹69.2 Cr
- Δ value
- up ₹2.8 Cr
- Status
- Added
- Weight
- 7.13%
- Δ weight
- down 0.08 pts
- Value
- ₹55.3 Cr
- Δ value
- down ₹1.1 Cr
- Status
- Trimmed
- Weight
- 5.89%
- Δ weight
- down 0.06 pts
- Value
- ₹45.7 Cr
- Δ value
- down ₹83 L
- Status
- Trimmed
- Weight
- 5.34%
- Δ weight
- down 0.62 pts
- Value
- ₹41.5 Cr
- Δ value
- down ₹5.2 Cr
- Status
- Trimmed
- Weight
- 4.34%
- Δ weight
- down 0.29 pts
- Value
- ₹33.7 Cr
- Δ value
- down ₹2.5 Cr
- Status
- Trimmed
- Weight
- 4.31%
- Δ weight
- down 0.11 pts
- Value
- ₹33.4 Cr
- Δ value
- down ₹1.1 Cr
- Status
- Trimmed
- Weight
- 4.12%
- Δ weight
- up 0.21 pts
- Value
- ₹32 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 3.52%
- Δ weight
- up 0.24 pts
- Value
- ₹27.3 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 3.21%
- Δ weight
- down 0.28 pts
- Value
- ₹24.9 Cr
- Δ value
- down ₹2.4 Cr
- Status
- Trimmed
- Weight
- 3.20%
- Δ weight
- up 0.14 pts
- Value
- ₹24.9 Cr
- Δ value
- up ₹87 L
- Status
- Added
- Weight
- 3.09%
- Δ weight
- down 0.24 pts
- Value
- ₹24 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 2.93%
- Δ weight
- down 0.23 pts
- Value
- ₹22.7 Cr
- Δ value
- down ₹2 Cr
- Status
- Trimmed
- Weight
- 2.74%
- Δ weight
- down 0.49 pts
- Value
- ₹21.3 Cr
- Δ value
- down ₹4 Cr
- Status
- Trimmed
- Weight
- 2.69%
- Δ weight
- up 0.35 pts
- Value
- ₹20.9 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
- Weight
- 2.14%
- Δ weight
- up 0.38 pts
- Value
- ₹16.6 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Weight
- 2.07%
- Δ weight
- up 0.15 pts
- Value
- ₹16.1 Cr
- Δ value
- up ₹1 Cr
- Status
- Added
- Weight
- 2.02%
- Δ weight
- down 0.17 pts
- Value
- ₹15.7 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 1.94%
- Δ weight
- up 1.94 pts
- Value
- ₹15 Cr
- Δ value
- up ₹15 Cr
- Status
- New
- Weight
- 1.70%
- Δ weight
- up 0.23 pts
- Value
- ₹13.2 Cr
- Δ value
- up ₹1.7 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.68%
- Δ weight
- down 0.27 pts
- Value
- ₹13 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 1.60%
- Δ weight
- down 0.26 pts
- Value
- ₹12.4 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 1.47%
- Δ weight
- down 0.03 pts
- Value
- ₹11.4 Cr
- Δ value
- down ₹32 L
- Status
- Trimmed
- Weight
- 1.43%
- Δ weight
- up 0.11 pts
- Value
- ₹11.1 Cr
- Δ value
- up ₹80 L
- Status
- Added
- Weight
- 1.29%
- Δ weight
- up 0.02 pts
- Value
- ₹10 Cr
- Δ value
- up ₹6 L
- Status
- Added
- Weight
- 1.20%
- Δ weight
- up 0.01 pts
- Value
- ₹9.3 Cr
- Δ value
- up ₹3 L
- Status
- Held
- Weight
- 1.19%
- Δ weight
- down 0.04 pts
- Value
- ₹9.2 Cr
- Δ value
- down ₹38 L
- Status
- Trimmed
- Weight
- 1.12%
- Δ weight
- down 0.11 pts
- Value
- ₹8.7 Cr
- Δ value
- down ₹90 L
- Status
- Trimmed
- Weight
- 1.09%
- Δ weight
- down 0.18 pts
- Value
- ₹8.5 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 1.04%
- Δ weight
- up 0.11 pts
- Value
- ₹8.1 Cr
- Δ value
- up ₹82 L
- Status
- Added
- Weight
- 1.01%
- Δ weight
- down 0.04 pts
- Value
- ₹7.8 Cr
- Δ value
- down ₹36 L
- Status
- Trimmed
- Weight
- 0.74%
- Δ weight
- down 0.01 pts
- Value
- ₹5.8 Cr
- Δ value
- down ₹9 L
- Status
- Trimmed
- Weight
- 0.66%
- Δ weight
- up <0.01 pts
- Value
- ₹5.1 Cr
- Δ value
- down ₹0 L
- Status
- Held
- Weight
- 0.44%
- Δ weight
- down 0.27 pts
- Value
- ₹3.5 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- 364 DAYS T-BILL 2024Debt
- Weight
- 0.16%
- Δ weight
- up <0.01 pts
- Value
- ₹1.3 Cr
- Δ value
- up ₹1 L
- Status
- Held
What changed, Jul 2023 to Aug 2023
New New positions (1)
- Concord Biotech Limited1.9% · ₹15 Cr
Exited Exited (0)
None.
Added Biggest additions
- Procter & Gamble Health Limitedup ₹2.9 Cr (+0.38% pts)
- Cipla Limitedup ₹2.8 Cr (+0.43% pts)
- Gland Pharma Limitedup ₹2.6 Cr (+0.35% pts)
- Acutaas Chemicals Limitedup ₹1.7 Cr (+0.23% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2023, the weight rose most in Pharmaceuticals & Biotechnology (+0.6 pts), and fell most in Healthcare Equipment & Supplies (−0.3 pts) and Healthcare Services (−0.3 pts).
- Pharmaceuticals & Biotechnology76.6% → 77.2%+0.6 pts
- Healthcare Equipment & Supplies1.9% → 1.6%−0.3 pts
- Healthcare Services19.6% → 19.3%−0.3 pts
- Pharmaceuticals1.2% → 1.1%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2020 | Jul 2022 | Feb 2023 | May 2023 | Jul 2023 | Aug 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 89.6% | 79.8% | 76.8% | 76.1% | 76.6% | 77.2% |
| Healthcare Services | 8.7% | 17.1% | 20.0% | 19.9% | 19.6% | 19.3% |
| Healthcare Equipment & Supplies | — | 1.6% | 2.0% | 1.9% | 1.9% | 1.6% |
| Pharmaceuticals | — | 0.7% | 1.2% | 1.6% | 1.2% | 1.1% |
| Insurance | — | — | — | 0.5% | 0.7% | 0.7% |
Allocation in Aug 2023change vs Jul 2023
- Pharmaceuticals & Biotechnology (24)77.2%▲ 0.6 pts
- Healthcare Services (6)19.3%▼ 0.3 pts
- Healthcare Equipment & Supplies (1)1.6%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Aug 2023
1.8%
▼ 0.3 pts vs Jul 2023
- Cash alone
- 1.7%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 1.4% – 2.2%
- lowest to highest · record 7.3% in Jul 2017
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.